Showing 172,441 - 172,460 results of 261,343 for search '(( 0 ((0 decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (nn decrease)) ))', query time: 2.75s Refine Results
  1. 172441
  2. 172442

    Hexadecenoic Fatty Acid Isomers in Human Blood Lipids and Their Relevance for the Interpretation of Lipidomic Profiles by Anna Sansone (1882819)

    Published 2016
    “…The fatty acid profile of morbidly obese subjects also showed significant increases of stearic acid (C18:0) and C20 omega-6, as well as decreases of oleic acid (9<i>cis</i>-18:1) and docosahexaenoic acid (C22:6 omega-3) as compared with lean healthy controls. …”
  3. 172443

    LBDNet inter-laboratory comparison at high doses of ionizing radiation using the dicentric plus caffeine assay by Ivonne Romero (21246775)

    Published 2025
    “…The 92.3%, 92.3%, and 61.5% of the 95% of the confidence interval of the estimated doses included the true radiation dose. The trueness was 0.9%, 4.4% and 9.6%. The Coefficients of Variation of the estimated doses were 14.5%, 16.1% and 17.8%. …”
  4. 172444

    Image_3_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  5. 172445

    Image_5_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  6. 172446

    Image_2_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  7. 172447

    Image_1_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  8. 172448

    Image_7_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  9. 172449

    Image_4_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.TIF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  10. 172450

    Image_8_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  11. 172451

    Image_11_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  12. 172452

    Image_10_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  13. 172453

    Image_6_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  14. 172454

    Image_9_The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040.PDF by Jiao Su (560028)

    Published 2024
    “…The age-standardized YLD and YLL rates decreased by an average of −0.21% (95% CI –0.26 to −0.16) and − 0.2% (95% CI –0.26 to −0.14) per year for overall MS from 1990 to 2019, respectively. …”
  15. 172455

    Changes in Copepod Community Structure in Response to Land-Based Activities along Alexandria Coastline, Mediterranean Sea by El Din, Nehad M. Nour [نهاد مصطفى نور الدين]

    Published 2000
    “…Diversity indices for the area heavily affected by agricultural discharge (1.8 - 2.6) were higher than for the areas impacted by sewage (1.6 - 1.9), mixed agricultural/industrial (1.4 - 1.6) and industrial (0.6 - 0.8) discharge. Freshwater species were recorded at nearshore stations opposite agricultural runoff where salinity declined to < 10 psu. …”
    Get full text
  16. 172456

    DataSheet_1_Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors.pdf by Hannah Schindler (11040891)

    Published 2022
    “…Lower baseline levels of TNF-RI were associated with longer PFS (hazard ratio [HR]= 0.42-0.54; p=0.014-0.009) and overall survival (HR=0.28-0.34, p=0.004-0.001) after both ICT and IO monotherapy. …”
  17. 172457

    Data_Sheet_1_Microbiome-Metabolome Responses in Ruminal Content and Feces of Lactating Dairy Cows With N-Carbamylglutamate Supplementation Under Heat Stress.docx by Yan Li (23143)

    Published 2022
    “…Forty-eight lactating Holstein cows (154 ± 13.6 days in milk) were assigned randomly to four treatments (n = 12), to receive 0, 15, 20, or 25 g/day of commercial NCG (proportion: 97.7%) for the period of 60 days. …”
  18. 172458

    DataSheet_1_Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern.docx by Ying-Zi Li (12291221)

    Published 2022
    “…Compared with NSTs, PIK3CA and TP53 mutation frequency showed difference in STs (47.1% vs 19.4%, p=0.039; 64.7% vs 87.5%, p=0.035).</p>Conclusions<p>In TNBC patients with STs, decrease in histologic grade and ki-67 index, as well as increase in PD-L1 and AR expression were observed when compared to those with NSTs, suggesting that TNBC patients with STs may better benefit from immune checkpoint inhibitors and/or AR inhibitors. …”
  19. 172459
  20. 172460

    PRISMAS flowchart of the screening process. by Xianghong Hu (17966261)

    Published 2024
    “…Within 24 h after hip surgery, PENG block significantly reduced postoperative opioid consumption (MD = -12.03, 95% CI: -21.47 to -2.59, <i>P</i> < 0.01, <i>I</i><sup><i>2</i></sup> = 97%), particularly in subpopulations undergoing hip replacement, hip fracture, or who had spinal anesthesia, and it significantly decreased dynamic pain scores, but not static scores, without increasing risk of nausea or vomiting or patient dissatisfaction. …”